Research from the Francis Crick Institute, the University of Cambridge, Imperial College London, the University of Liverpool, the University of Cape Town, and UKHSA has linked molnupiravir, an antiviral drug for COVID-19 infections, and a pattern of mutations in the SARS-CoV-2 virus.
Molnupiravir, an antiviral medication for COVID-19 infections, and a pattern of mutations in the SARS-CoV-2 virus have been linked, according to research from the Francis Crick Institute, the University of Cambridge, Imperial College London, the University of Liverpool, the University of Cap